Search results for "lymph"

showing 10 items of 4590 documents

Rituximab in Combination with CHOP in Patients with Follicular Lymphoma: Analysis of Treatment Outcome of 552 Patients Treated in a Randomized Trial …

2008

Abstract We have previously reported that compared to CHOP alone the addition of Rituximab (R) to CHOP significantly increases the response rate (RR), the time to treatment failure (TTF) and also the overall survival (OS) in patients with newly diagnosed advanced follicular lymphoma. However, in the previous report, the median observation time was short with 18 months and no data were reported on the outcome of different risk groups according to the FLIPI (Hiddemann et al., Blood 2005). We now report on the treatment outcome of 552 patients with advanced stage follicular lymphoma randomized between R-CHOP versus CHOP alone after a median follow up of 58 months. Responding patients < …

medicine.medical_specialtybusiness.industryImmunologyFollicular lymphomaAlpha interferonCell BiologyHematologyCHOPDebulkingmedicine.diseaseBiochemistryChemotherapy regimenGastroenterologySurgerylaw.inventionRandomized controlled trialMedian follow-uplawInternal medicinemedicineRituximabbusinessmedicine.drugBlood
researchProduct

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study

2015

Acquired hemophilia A (AHA) is caused by autoantibodies against factor VIII (FVIII). Immunosuppressive treatment (IST) results in remission of disease in 60% to 80% of patients over a period of days to months. IST is associated with frequent adverse events, including infections as a leading cause of death. Predictors of time to remission could help guide IST intensity but have not been established. We analyzed prognostic factors in 102 prospectively enrolled patients treated with a uniform IST protocol. Partial remission (PR; defined as no active bleeding, FVIII restored >50 IU/dL, hemostatic treatment stopped >24 hours) was achieved by 83% of patients after a median of 31 days (range 7-362…

medicine.medical_specialtybusiness.industryImmunologyHazard ratioAutoantibodyCell BiologyHematologyOdds ratioBiochemistryGastroenterologyConfidence intervalSurgeryhemic and lymphatic diseasesInternal medicinemedicineAcquired hemophiliaAdverse effectbusinessSurvival analysisCause of deathBlood
researchProduct

Epidemiological Characterization and Determination of TP53 and IGHV Mutational Status of a Large Series of Previously-Untreated Chronic Lymphocytic L…

2021

Abstract Introduction: Among the genetic lesions described in chronic lymphocytic leukemia (CLL), TP53 and IGHV mutational status are well-established prognostic biomarkers. While mutations resulting in dysregulation of TP53 are associated with chemo-resistance, mutated IGHV (IGHV-M) identifies a good prognosis and unmutated (IGHV-UM) is associated with an aggressive clinical outcome. Thus, molecular assessment of TP53 and IGHV mutational status is recommended to make treatment decisions. Moreover, 30% of CLL patients have a highly homologous complementarity-determining region 3 (CDR3), allowing their classification in subsets based on the stereotypical B-cell receptor immunoglobulins (BcR …

medicine.medical_specialtybusiness.industryImmunologyLarge seriesCell BiologyHematologyBiochemistryEpidemiologyImmunologymedicineMutational statusIGHV@businessUntreated Chronic Lymphocytic LeukemiaBlood
researchProduct

Granulomas en dermatopatología: principales entidades. Parte I

2021

This series of 2 articles on dermatopathologic diagnoses reviews conditions in which granulomas form. Part 1 clarifies concepts, discusses the presentation of different types of granulomas and giant cells, and considers a large variety of noninfectious diseases. Some granulomatous diseases have a metabolic origin, as in necrobiosis lipoidica. Others, such as granulomatous mycosis fungoides, are related to lymphomas. Still others, such as rosacea, are so common that dermatologists see them nearly daily in clinical practice.

medicine.medical_specialtybusiness.industryLanghans giant cellGeneral Medicinemedicine.diseaseDermatologyNecrobiosis lipoidicaClinical PracticeGiant cellRosaceaTouton giant cellhemic and lymphatic diseasesGranulomaMedicineDermatopathologybusinessActas Dermo-Sifiliográficas
researchProduct

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

2013

We applied prophylactic CD8-depleted (CD8depl) donor lymphocyte infusions (DLI) in the setting of T-cell depleted reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT) in a phase I/II trial. T-cell depletion was carried out by the use of high-dose Alemtuzumab (100 mg or 60 mg for unrelated or sibling donor transplantation, respectively). We have demonstrated the feasibility of this approach after having treated 23 patients in this protocol (Meyer et al. Blood 2007). From 2004 to 2011, 134 patients with different hematologic diseases were included and followed for a median observation time of 1.5 years after transplantation (range, 1.5-9 years). Median age was 56 years …

medicine.medical_specialtybusiness.industryLymphocytemedicine.medical_treatmentImmunologyCell BiologyHematologyHematopoietic stem cell transplantationmedicine.diseaseBiochemistryGastroenterologylaw.inventionSurgeryTransplantationmedicine.anatomical_structureGraft-versus-host diseaseRandomized controlled triallawInternal medicineCohortmedicineAlemtuzumabbusinessCD8medicine.drugBlood
researchProduct

Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin

2014

medicine.medical_specialtybusiness.industryLymphoma Non-HodgkinUltrasoundDermatologymedicine.diseaseDermatologyHumansMedicineHodgkin lymphomaFemalePrurigoDermatological disordersbusinessPrurigo nodularisAgedUltrasonographyInternational Journal of Dermatology
researchProduct

Malignant Melanoma S3-Guideline “Diagnosis, Therapy and Follow-up of Melanoma”

2013

This first German evidence-based guideline for cutaneous melanoma was developed under the auspices of the German Dermatological Society (DDG) and the Dermatologic Cooperative Oncology Group (DeCOG) and funded by the German Guideline Program in Oncology. The recommendations are based on a systematic literature search, and on the consensus of 32 medical societies, working groups and patient representatives. This guideline contains recommendations concerning diagnosis, therapy and follow-up of melanoma. The diagnosis of primary melanoma based on clinical features and dermoscopic criteria. It is confirmed by histopathologic examination after complete excision with a small margin. For the stagin…

medicine.medical_specialtybusiness.industryMelanomamedicine.medical_treatmentSentinel lymph nodeIpilimumabDermatologyGuidelinemedicine.diseaseSurgeryMetastasisCutaneous melanomamedicineAdjuvant therapyLymphadenectomyRadiologybusinessmedicine.drugJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

MR-Tomographie bei Innenbandverletzungen des Kniegelenkes

1992

Frequency and characteristics of lesions of the medial collateral ligaments (MCL) were studied by MRI in 155 patients with trauma to the knee. There were abnormalities of the MCL in 38% of cases with ligamentous injuries and in 27% these were combined with meniscal tears. 11% of these patients showed isolated rupture of MCL and as a result of the MRI findings were treated conservatively. By means of T2*-weighted images the individual lesions could be accurately localised. Characteristic findings have been defined.

medicine.medical_specialtybusiness.industryMeniscal tearsAnatomyKnee Jointmedicine.anatomical_structurehemic and lymphatic diseasesLigamentMedicineRadiology Nuclear Medicine and imagingTomographyRadiologybusinessMri findingsRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Treg activation status depends on psoriasis therapy regime

2020

medicine.medical_specialtybusiness.industryPsoriasismedicineMEDLINEHumansPsoriasisTh17 CellsDermatologymedicine.diseasebusinessT-Lymphocytes RegulatoryDermatologyJDDG: Journal der Deutschen Dermatologischen Gesellschaft
researchProduct

Linfedema: Diagnóstico diferencial y pruebas complementarias

2010

Objetivo Realizar una revisión y actualización del diagnóstico diferencial del linfedema y de las pruebas complementarias necesarias y presentar un algoritmo simplificado del diagnóstico. Estrategia de búsqueda. Se buscaron los artículos originales en las principales bases de datos: National Guideline Clearinghouse, Guidelines Finder de la National Electronic Library for Health del NHS británico, Cochrane Central Register of Controlled Trials, Web of Knowledge y Medline (19962009), y las monografías más relevantes sobre linfedema. Selección de estudios.Se valoró la relevancia de los artículos mediante la lectura del título y resumen, y se analizó el texto completo de aquellos considerados r…

medicine.medical_specialtybusiness.industryRehabilitationMEDLINEPhysical Therapy Sports Therapy and Rehabilitationmedicine.diseaseElectronic librarySurgeryLymphedemaWeb of knowledgeSang CirculaciómedicineMedical physicsRelevance (information retrieval)Corbusiness
researchProduct